PBE vs. HELX ETF Comparison
Comparison of PowerShares Dynamic Biotech & Genome (PBE) to Franklin Genomic Advancements ETF (HELX)
PBE
PowerShares Dynamic Biotech & Genome
PBE Description
The PowerShares Dynamic Biotechnology & Genome Portfolio (Fund) is based on the Dynamic Biotech & Genome IntellidexSM Index (Intellidex Index). The Fund will normally invest at least 90% of its total assets in common stocks that comprise the Index. The Intellidex Index is designed to provide capital appreciation by thoroughly evaluating companies based on a variety of investment merit criteria, including price momentum, earnings momentum, quality, management action, and value. The Underlying Intellidex Index is comprised of common stocks of 30 US biotechnology and genome companies. These are companies that are principally engaged in the research, development, manufacture and marketing and distribution of various biotechnological products, services and processes and companies that benefit significantly from scientific and technological advances biotechnology and genetic engineering and reseach. The Fund and the Index are rebalanced and reconstituted quarterly in February, May, August and November.
Grade (RS Rating)
Last Trade
$69.14
Average Daily Volume
6,628
30
HELX
Franklin Genomic Advancements ETF
HELX Description
Seeks capital appreciation by investing in innovative companies related to genomic-based technologies designed to enhance the quality of life. Provides access to companies benefitting from or facilitating the use of new research including DNA sequencing, gene editing and personalized medicine Uses bottom-up fundamental research conducted by dedicated, industry-specific analysts to identify disruptive business models at the right stage for investment Actively managed by a seasoned portfolio management team that is based in Silicon Valley and has a long history of investing in the craft of innovationGrade (RS Rating)
Last Trade
$30.51
Average Daily Volume
1,729
51
Performance
| Period | PBE | HELX |
|---|---|---|
| 30 Days | -0.97% | -4.73% |
| 60 Days | -3.80% | -8.33% |
| 90 Days | 0.98% | -6.94% |
| 12 Months | 26.96% | 16.57% |
10 Overlapping Holdings
PBE Overweight 20 Positions Relative to HELX
PBE Underweight 41 Positions Relative to HELX
| Symbol | Grade | Weight | |
|---|---|---|---|
| MEDP | F | -5.91% | |
| VRTX | D | -5.79% | |
| DHR | D | -5.27% | |
| LLY | F | -4.97% | |
| TMO | D | -4.96% | |
| KRYS | C | -4.25% | |
| AZN | F | -2.68% | |
| CTVA | A | -2.27% | |
| INSM | D | -2.11% | |
| A | D | -2.08% | |
| IONS | F | -2.05% | |
| BRKR | D | -2.01% | |
| CDNS | C | -1.98% | |
| CRL | F | -1.95% | |
| BNTX | B | -1.85% | |
| EXAS | A | -1.73% | |
| ICLR | F | -1.66% | |
| RCKT | F | -1.57% | |
| SRPT | D | -1.56% | |
| RVTY | C | -1.48% | |
| RARE | D | -1.46% | |
| TWST | F | -1.22% | |
| IQV | F | -1.13% | |
| VYGR | C | -1.11% | |
| LH | A | -0.97% | |
| BBIO | D | -0.92% | |
| LGND | A | -0.88% | |
| AZTA | F | -0.86% | |
| BEAM | F | -0.86% | |
| NTLA | F | -0.83% | |
| CDMO | C | -0.8% | |
| MRNA | F | -0.79% | |
| CRSP | C | -0.65% | |
| RXRX | F | -0.57% | |
| BIO | A | -0.53% | |
| AVTR | F | -0.5% | |
| FDMT | F | -0.44% | |
| BMY | A | -0.31% | |
| SLP | F | -0.3% | |
| DVAX | A | -0.2% | |
| ARE | F | -0.16% |
PBE: Top Represented Industries & Keywords
HELX: Top Represented Industries & Keywords
Compare ETFs
